该药为注射剂,于2008年3月由美国食品药品管理局批准上市,用于治疗慢性淋巴细胞性白血病(chronic lymphocyticleukaemia,CLL)。
基于4个网页-相关网页
慢性淋巴细胞性白血病 CLL ; chronic lymphocytic leukemia ; lymphocytic leukemia
急性淋巴细胞性白血病 ALL ; acute lymphoblastic leukemia ; Acute Lymphocytic Leukemia ; pediatric acute lymphoblastic leukemia
急性淋巴细胞性白血病也称急性淋巴母细胞性白血病，又称急性儿童期白血病。
Acute lymphocytic leukemia is also known as acute lymphoblastic leukemia and acute childhood leukemia.
与急性髓细胞性白血病相比，急性淋巴细胞性白血病细胞免疫功能更为低下。
Compared with acute myelogenous leukemia, patients with acute lymphoblastic leukemia had more poor cellular immune function.
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
应用推荐